CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230
- in 4 filings, $2K under 10b5-1 plans
Net −$2,230. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-27 | Henn Matthew R. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −12,622 | 0 | ||
| 2024-10-27 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise 10b5-1 | +13,500 | 137,673 | ||
| 2024-10-27 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise · Restricted Stock Units 10b5-1 | −13,500 | 0 | ||
| 2024-10-27 | Shaff Eric D. CEO and President | Option exercise 10b5-1 | +27,837 | 173,830 | ||
| 2024-10-27 | Shaff Eric D. CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −27,837 | 0 | ||
| 2024-10-27 | Young Teresa L. See Remarks | Option exercise 10b5-1 | +11,360 | 91,466 | ||
| 2024-10-27 | Young Teresa L. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −11,360 | 0 | ||
| 2024-08-16 | DesRosier Thomas Chief Legal Officer and EVP | Sale 10b5-1 | −873 | $0.84 | $733 | 124,173 |
| 2024-08-16 | von Moltke Lisa See Remarks | Sale 10b5-1 | −973 | $0.84 | $817 | 21,013 |
| 2024-08-16 | Henn Matthew R. See Remarks | Sale 10b5-1 | −923 | $0.84 | $775 | 67,247 |
| 2024-08-16 | Shaff Eric D. CEO and President | Sale 10b5-1 | −2,518 | $0.84 | $2K | 145,993 |
| 2024-08-16 | Young Teresa L. See Remarks | Sale 10b5-1 | −728 | $0.84 | $612 | 80,106 |
| 2024-08-16 | Ege David S. See Remarks | Sale 10b5-1 | −1,128 | $0.84 | $948 | 77,575 |
| 2024-08-15 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise 10b5-1 | +2,656 | 125,046 | ||
| 2024-08-15 | DesRosier Thomas Chief Legal Officer and EVP | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 26,563 | ||
| 2024-08-15 | von Moltke Lisa See Remarks | Option exercise 10b5-1 | +2,969 | 21,986 | ||
| 2024-08-15 | von Moltke Lisa See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,969 | 29,688 | ||
| 2024-08-15 | Henn Matthew R. See Remarks | Option exercise 10b5-1 | +2,813 | 68,170 | ||
| 2024-08-15 | Henn Matthew R. See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,813 | 28,125 | ||
| 2024-08-15 | Shaff Eric D. CEO and President | Option exercise 10b5-1 | +7,813 | 148,511 |
Page 11 of 13 · 254 trades